{"id":432263,"title":"Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T07:39:23.698000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-statement-investigational-use-marketed-drugs-clinical-trials.html","snippet":"Notice to Stakeholders: Statement on the Investigational Use of Marketed Drugs in Clinical Trials 1) Context This statement provides guidance to clinical trial applicants about the investigational use of marketed drugs within clinical trials in Canada. It will serve as interim…","rawSnapshotUrl":"/api/snapshots/raw/432263","browseUrl":"https://replay.healtharchive.ca/job-6/20260102073923/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-statement-investigational-use-marketed-drugs-clinical-trials.html#ha_snapshot=432263","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}